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While it is difficult
to say that Steve
Jobs was the inspi-
ration for JACC:
Heart Failure, his
philosophy and im-
plementation was
certainly analogous
in many respects to
our own vision.This past month I finished reading the biography of Steve Jobs by Walter Isaac-son (1) and an Editor-in-Chief was selected and a timeline finalized for thebirth of a new journal: JACC: Heart Failure. We have been fortunate enough to
ttract Chris O’Connor of Duke University as the Editor, and we will begin accepting
ubmissions to JACC: Heart Failure on July 1 of this year with the first issue to appear
n January/February of 2013. Although reading Jobs’ biography and starting the new jour-
al might seem totally unrelated, in fact, they have a number of parallels. So I thought that I
ight try to draw on some of these analogies in this month’s Editor’s Page.
It has been the general impression that the JACC journals are doing reasonably well.
e continue to receive an increasing number of submissions, readership surveys indicate
hat the great majority of cardiologists read JACC journals regularly, and our impact fac-
ors (as flawed as the metric is) is among the top tier of cardiology publications. Given
his status, one would wonder why we would seek to make any major changes. However,
s Jobs told Isaacson in an interview, he always tried to keep moving and innovating.
his was, of course, well exhibited by the sequential introduction of the iPOD,
PHONE, and iPAD. Drawing upon the music industry, Jobs pointed out how the
eatles and Bob Dylan kept evolving and refining their art. In fact, he quoted Dylan as
aying “if you’re not busy being born, you’re busy dying.” We are in complete agreement
ith this philosophy at JACC, and the creation of JACC: Heart Failure is the latest evi-
ence of this commitment.
We are aware that many will question whether another cardiology journal is necessary.
urveys often record that cardiovascular specialists cannot keep up with all the publica-
ions that currently exist, much less find the time to devote to a new one. There was
ittle enthusiasm among our readers prior to the initiation of JACC: Cardiovascular
maging and JACC: Cardiovascular Interventions. Nevertheless, these new publications
ave been a resounding success, and are the leading journals in their respective fields.
ur actions in this regard parallel the philosophy espoused by Jobs to figure out what
ustomers are going to want before they realize it themselves. He suggests that prior to
he creation of automobiles, if people had been asked they would have requested a faster
orse. I certainly never yearned for a digital tablet, but I now use my iPAD regularly.
e have faith that JACC: Heart Failure will meet with similar success.
The creation of new journals is certainly consistent with the mission of the American
ollege of Cardiology to bring new knowledge to its members. What better way to edu-
ate than through scholarly publications. In addition, mother JACC currently has an ac-
eptance rate of approximately 10%, and many of the very meritorious submissions that
e must reject due to page limitations are in the field of heart failure. In addition to
irect submissions, the new journal will enable us to deliver many of these worthwhile
tudies to the cardiovascular community.
There are, of course, a number of subject areas within cardiovascular medicine thatould have been selected for a new journal. We did consider other topics, such as pre-
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that made it the clear choice. It is the final common
pathway in the natural history of most cardiovascular dis-
orders. Coronary, valve, myocardial, and congenital car-
diac diseases all often ultimately lead to heart failure. The
prevalence of diastolic abnormalities in our increasingly
obese, diabetic, hypertensive, and elderly society has also
increased the prevalence of cardiac failure, which is now
the most rapidly increasing category of cardiac patients.
Heart failure is a condition that is truly encountered and
managed by virtually all cardiovascular specialists.
Interestingly, the field of heart failure has been majorly
impacted and expanded by advances in electrophysiology,
and vice versa. Heart failure frequently leads to cardiac
arrhythmias, and as these patients survive longer, the inci-
dence of rhythm disorders is increasing proportionately. It
is the common experience that most patients with heart
failure ultimately exhibit some abnormality of rhythm or
conduction, and that the largest category of patients with
electrophysiological disturbances are those with heart fail-
ure. Moreover, the development of new therapies for
heart rhythm disorders, such as cardiac resynchronization
and implantable defibrillators, has markedly increased the
armamentarium for the treatment of heart failure. Ac-
cordingly, the knowledge base required for the optimal
management of these patients has expanded. In fact, in
classifying manuscripts under topic headings for the cover
of each JACC issue, I have encountered so many papers
that deal with electrophysiological disturbances in heart
failure patients that we strongly considered creating a sin-
gle journal devoted to both disorders.
The field of heart failure has also been impacted by the
emergence of left ventricular assist devices (LVADs) both
as bridge and destination therapy. Patients who had un-
dergone cardiac transplantation always presented a chal-
lenge to the general cardiologist. Now it is becoming pro-
gressively more commonplace to have patients in the
hospital in whom LVADs have been placed. Until re-
cently I always felt very comfortable in covering the heart
failure service when necessary. Now I feel intimidated and
inadequate if LVAD patients are included. It is not surpris-
ing, therefore, that the American Board of Internal Medi-
cine has established a Certificate of Added Qualifications for
Advanced Heart Failure and Cardiac Transplantation.
All of the foregoing issues give strong support to the
rationale of creating a new publication devoted to themanagement of heart failure. However, just as Steve Jobs
had the goal to create a constellation of products that
worked together to serve the multiple wishes of his cus-
tomers, we at JACC seek to have an integrated line of
publications to serve the same purpose. This clearly has
been a major driver in developing the new journal. Jobs
created a system at Apple that could fulfill the music,
telephone, and digital consumption needs of customers
through the integrated group of iPOD, iPHONE, iPAD,
and iTunes products. Similarly, our vision is to ultimately
provide our readers with a co-ordinated group of publica-
tions that cover the spectrum of cardiovascular diseases.
JACC: Heart Failure is just the latest in that JACC family
line of journals.
While it is difficult to say that Steve Jobs was the in-
spiration for JACC: Heart Failure, his philosophy and im-
plementation was certainly analogous in many respects to
our own vision. Having been the first cardiology journal
to create daughter publications devoted to specific cardio-
vascular disciplines, it was almost mandatory that we not
rest but rather continue to evolve. JACC: Heart Failure
will further round out the integrated JACC family of jour-
nals, and we are convinced that our readers will embrace
this new publication as avidly as they did our Imaging and
Interventions offspring. Heart failure is clearly one of the
most ubiquitous and rapidly expanding conditions in car-
diovascular medicine. With the expertise and enthusiasm
of Chris O’Connor leading the effort, we anticipate that
July 1, 2012, will bring a wealth of submissions and that
January/February 2013 will provide a spectacular inaugural
issue. Our belief is that the rationale for JACC: Heart
Failure shares much in common with the philosophy of
Steve Jobs and Apple. Our only hope, and anticipation, is
that we be nearly as successful.
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